Dalton Pharma Service's Integrated Single Site Model

This integrated single‑site model brings the entire development and manufacturing lifecycle—API development, GMP production, formulation, aseptic fill‑finish, and quality control—under one roof, governed by a unified quality management system. By eliminating handoffs between vendors, the approach preserves process knowledge, reduces redundant qualification activities, and ensures more predictable transitions across phases. Development teams, manufacturing specialists, and quality personnel operate within a continuous, interconnected framework, enabling rapid feedback, aligned decision‑making, and fewer late‑stage surprises.

On‑site API manufacturing eliminates external tech transfers, while tightly integrated formulation and sterile processing reduce contamination risks and streamline validation. A single governance structure supports unified change control, deviation trending, and lifecycle oversight, strengthening inspection readiness and accelerating batch release. This model is particularly beneficial for sterile and complex programs where speed, regulatory confidence, and continuity are essential. By consolidating critical activities within one coordinated environment, organizations gain faster execution, clearer accountability, and reduced overall program risk from early development through commercial supply.